Tolnaftate
(FUSNMLFNXJSCDI-UHFFFAOYSA-N)
Structure
- SMILES
- Cc1cccc(c1)N(C(=S)Oc1ccc2c(c1)cccc2)C
- Type(s)
- Approved; Investigational; Vet_approved
- ATC code(s)
- D01AE18
- Molecular Formula:
- C19H17NOS
- Molecular Weight:
- 307.409
- Log P:
- 4.9483
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 0
- TPSA:
- 44.56
- CAS Number(s):
- 2398-96-1; 94256-64-1
Synonym(s)
1.
Tolnaftate
2.
Aftate
3.
Breezee
4.
Chinofungin
5.
Chlorisept
6.
Curatin
7.
Genaspor
8.
Micoisdin
9.
NP-27
10.
Ony-Clear
11.
Sporiline
12.
Tinactin
13.
Tinaderm
14.
Tinatox
15.
Tineafax
16.
Ting
17.
Tolnaftat Purder N
18.
Tonoftal
19.
ZeaSorb
20.
NP 27
21.
NP27
22.
Ony Clear
23.
Purder N, Tolnaftat
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 40 | US FAERS | |
| 2 | Drug administered at inappropriate site | FAERS: 13 | US FAERS | |
| 3 | Accidental exposure to product | FAERS: 7 | US FAERS | |
| 4 | Burning sensation | FAERS: 7 | US FAERS | |
| 5 | Drug ineffective for unapproved indication | FAERS: 7 | US FAERS | |
| 6 | Expired product administered | FAERS: 6 | US FAERS | |
| 7 | Product quality issue | FAERS: 5 | US FAERS | |
| 8 | Product use issue | FAERS: 5 | US FAERS | |
| 9 | Incorrect drug administration duration | FAERS: 4 | US FAERS | |
| 10 | Therapeutic product ineffective | FAERS: 4 | US FAERS | |
| 11 | Application site pain | FAERS: 3 | US FAERS | |
| 12 | Drug prescribing error | FAERS: 3 | US FAERS | |
| 13 | Expired drug administered | FAERS: 3 | US FAERS | |
| 14 | Pain | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Application site erythema | FAERS: 2 | US FAERS | |
| 16 | Nausea | FAERS: 2 | US FAERS | |
| 17 | Pruritus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Therapeutic product ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 19 | Abasia | FAERS: 1 | US FAERS | |
| 20 | Angioedema | FAERS: 1 | US FAERS | |
| 21 | Application site burn | FAERS: 1 | US FAERS | |
| 22 | Application site pruritus | FAERS: 1 | US FAERS | |
| 23 | Application site scab | FAERS: 1 | US FAERS | |
| 24 | Application site warmth | FAERS: 1 | US FAERS | |
| 25 | Arthralgia | FAERS: 1 | US FAERS | |
| 26 | Asthma | FAERS: 1 | US FAERS | |
| 27 | Blood blister | FAERS: 1 | US FAERS | |
| 28 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 29 | Drug Dependence | FAERS: 1 | US FAERS | |
| 30 | Drug abuser | FAERS: 1 | US FAERS | |
| 31 | Electrocardiogram abnormal | FAERS: 1 | US FAERS | |
| 32 | Erythema | FAERS: 1 | US FAERS | |
| 33 | Eye irritation | FAERS: 1 | US FAERS | |
| 34 | Fatigue | FAERS: 1 | US FAERS | |
| 35 | Hordeolum | FAERS: 1 | US FAERS | |
| 36 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 37 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 38 | Joint swelling | FAERS: 1 | US FAERS | |
| 39 | Laceration | FAERS: 1 | US FAERS | |
| 40 | Limb discomfort | FAERS: 1 | US FAERS | |
| 41 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 42 | Lymphoma | FAERS: 1 | US FAERS | |
| 43 | Medication tampering | FAERS: 1 | US FAERS | |
| 44 | Nipple pain | FAERS: 1 | US FAERS | |
| 45 | Nonspecific reaction | FAERS: 1 | US FAERS | |
| 46 | Overdose | FAERS: 1 | US FAERS | |
| 47 | Product caught fire | FAERS: 1 | US FAERS | |
| 48 | Product monitoring error | FAERS: 1 | US FAERS | |
| 49 | Product package associated injury | FAERS: 1 | US FAERS | |
| 50 | Rash erythematous | FAERS: 1 | US FAERS | |
| 51 | Shock | FAERS: 1 | US FAERS | |
| 52 | Skin irritation | FAERS: 1 | US FAERS | |
| 53 | Skin texture abnormal | FAERS: 1 | US FAERS | |
| 54 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 55 | Tinea Pedis | FAERS: 1 | US FAERS | |
| 56 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 57 | Vomiting | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.